Polymeric micelles as a new drug carrier system and their required considerations for clinical trials

Bibliography

• Bader H, Ringsdorf H, Schmidt B. Watersoluble polymers in medicine. Angew Chem Int Ed Engl 1984;123/124:457-85
   Google Scholar
• Pratten MK, Lloyd JB, Ringsdorf H. Micelle-forming block copolymers: pinocytosis by macrophages and interaction with model membranes. Makromol Chem 1985;186:725-33
   Web of Science ®Google Scholar
• Yokoyama M, Inoue S, Sakurai Y. Molecular design for missile drug: synthesis of adriamycin conjugated with IgG using poly(ethylene glycol)-poly(aspartic acid) block copolymer as intermediate carrier. Makromol Chem 1989;190:2041-54
   Web of Science ®Google Scholar
• Kabanov AV, Alakhov VY, Kabanov VA, The neuroleptic activity of haloperidol increases after its solubilization in surfactant micelles: micelles as microcontainers for drug targeting. FEBS Lett 1989;258:343-5
   PubMed Web of Science ®Google Scholar
• Yokoyama M, Okano T, Inoue S, Toxicity and antitumor activity against solid tumors of micelle-forming polymeric drug and its extremely long circulation in blood. Cancer Res 1991;51:3229-36
   PubMed Web of Science ®Google Scholar
• Kwon GS, Yokoyama M, Kataoka K, Enhanced tumor accumulation and prolonged circulation times of micelle-forming poly(ethylene oxide-aspartate) block copolymer-adriamycin conjugates. J Control Release 1994;29:17-23
   Web of Science ®Google Scholar
• Yokoyama M, Okano T, Kataoka K, Selective delivery of adriamycin to a solid tumor using a polymeric micelle carrier system. J Drug Targeting 1999;7:171-86
   PubMed Web of Science ®Google Scholar
• Batrakova EV, Alakhov VY, Kabanov AV, Anthracycline antibiotics non-covalently incorporated into the block copolymer micelles: in vivo evaluation of anti-cancer activity. Br J Cancer 1996;74:1545-52
   PubMed Web of Science ®Google Scholar
• Kabanov AV, Alakhov VY. Micelles of amphiphilic block copolymers as vehicles for drug delivery. In: Alexandridis P, Lindman B, editors, Amphiphilic block copolymers: self assembly and applications. Elsevier, Netherlands; 1997. p. 1-31
   Google Scholar
• Yu BG, Okano T, Kwon GS, Polymeric micelles for drug delivery: solubilization and haemolytic activity of amphotericin B. J Control Release 1998;53:131-6
   PubMed Web of Science ®Google Scholar
• Rolland A, O'Mullane J, Petrak K, New macromolecular carriers for drugs. I. Preparation and characterization of poly(oxyethylene-b-isoprene-b-oxyethylene) block copolymer aggregates. J Appl Polym Sci 1992;44:1195-203
   Web of Science ®Google Scholar
• Inoue T, Nakamae K, Hoffman AS, An AB block copolymer of oligo(methyl methacrylate) and poly(acrylic acid) for micellar delivery of hydrophobic drugs. J Control Release 1998;51:221-9
   PubMed Web of Science ®Google Scholar
• Zhang X, Burt HM, Hunter WL, An investigation of the antitumor activity and biodistribution of polymeric micellar paclitaxel. Cancer Chemother Pharmacol 1997;40:81-6
   PubMed Web of Science ®Google Scholar
• Matsumura Y, Kataoka K. Preclinical and clinical studies of anticancer agent-incorporating polymer micelles. Cancer Sci 2009;100:572-9
   PubMed Web of Science ®Google Scholar
• Matsumura Y. Polymeric micellar delivery systems in oncology. Jpn J Clin Oncol 2008;38:793-802
   PubMed Web of Science ®Google Scholar
• Matsumura Y. Poly (amino acid) micelle nanocarriers in preclinical and clinical studies. Adv Drug Deliv Rev 2008;60:899-914
   PubMed Web of Science ®Google Scholar
• Matsumura Y, Hamaguchi T, Watanabe N, Phase I clinical trial and pharmacokinetic evaluation of NK911, a micelle-encapsulated doxorubicin. Br J Cancer 2004;91:1775-81
   PubMed Web of Science ®Google Scholar
• Hamaguchi T, Kato K, Matsumura Y, A phase I and pharmacokinetic study of NK105, a paclitaxel-incorporating micellar nanoparticle formulation. Br J Cancer 2007;97:170-6
   PubMed Web of Science ®Google Scholar
• Danson S, Alakhov V, Ranson M, Phase I dose escalation and pharmacokinetic study of pluronic polymer-bound doxorubicin (SP1049C) in patients with advanced cancer. Br J Cancer 2004;90:2085-91
   PubMed Web of Science ®Google Scholar
• Kim DW, Kim SY, Heo DS, Multicenter phase II trial of Genexol-PM, a novel Cremophor-free, polymeric micelle formulation of paclitaxel, with cisplatin in patients with advanced non-small-cell lung cancer. Ann Oncol 2007;18:2009-14
   PubMed Web of Science ®Google Scholar
• Lee KS, Chung HC, Ro J, Multicenter phase II trial of Genexol-PM, a Cremophor-free, polymeric micelle formulation of paclitaxel, in patients with metastatic breast cancer. Breast Cancer Res Treat 2008;108:241-50
   PubMed Web of Science ®Google Scholar
• Park SR, Oh DY, Kim HK, A multi-center, late phase II clinical trial of Genexol (paclitaxel) and cisplatin for patients with advanced gastric cancer. Oncol Rep 2004;12:1059-64
   PubMed Web of Science ®Google Scholar
• Kim TY, Kim DW, Bang YJ, Phase I and pharmacokinetic study of Genexol-PM, a cremophor-free, polymeric micelle-formulated paclitaxel, in patients with advanced malignancies. Clin Cancer Res 2004;10:3708-16
   PubMed Web of Science ®Google Scholar
• Christian DA, Minko T, Discher DE, Flexible filaments for in vivo imaging and delivery: persistent circulation of filomicelles opens the dosage window for sustained tumor shrinkage. Mol Pharm 2009;6:1343-52
   PubMed Web of Science ®Google Scholar
• Geng Y, Minko T, Discher DE, Shape effects of filaments versus spherical particles in flow and drug delivery. Nat Nanotechnol 2007;2:249-55
   PubMed Web of Science ®Google Scholar
• Tuzar Z, Kratochvil P. Block and graft copolymer micelles in solution. Adv Coll Interface Sci 1976;6:201-32
   Web of Science ®Google Scholar
• Aliabadi M, Lavasanifar A. Polymeric micelles for drug delivery. Expert Opinion Drug Deliv 2006;3:139-62
   PubMedGoogle Scholar
• Kwon GS. Polymeric micelles for delivery of poorly water-soluble compounds. Crit Rev Ther Drug Carrier Syst 2003;20:357-403
   PubMed Web of Science ®Google Scholar
• Adams ML, Lavasanifar A, Kwon GS. Amphiphilic block copolymers for drug delivery. J Pharm Sci 2003;92:1343-55
   PubMed Web of Science ®Google Scholar
• Yokoyama M. Block copolymers as drug carriers. Crit Rev Ther Drug Carrier Syst 1992;9:213-48
   PubMed Web of Science ®Google Scholar
• Yokoyama M. Polymeric micelles for the targeting of hydrophobic drugs. In: Kwon GS, editor, Drug and pharmaceutical sciences polymeric drug delivery systems, Taylor & Francis vol. 148; 2005. p. 533-75
   Google Scholar
• Yokoyama M. Polymeric micelles as nano-sized drug carrier systems. In: Y Tabata, editor, Nanoparticles for pharmaceutical applications. American Scientific Publishers; Boca Raton 2007. p. 63-72
   Google Scholar
• Tardi PG, Boman NL, Cullis PR. Liposomal doxorubicin. J Drug Target 1996;4:129-40
   PubMed Web of Science ®Google Scholar
• Gabizon AA, Shmeeda H, Zalipsky S. Pros and cons of the liposome platform in cancer drug targeting. J Liposome Res 2006;16:175-83
   PubMed Web of Science ®Google Scholar
• Matsumura Y, Maeda H. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res 1986;46:6387-92
   PubMed Web of Science ®Google Scholar
• Maeda H, Sawa T, Konno T. Mechanism of tumor-targeted delivery of macromolecular drugs, including the EPR effect in solid tumor and clinical overview of the prototype polymeric drug SMANCS. J Control Release 2001;74:47-61
   PubMed Web of Science ®Google Scholar
• Maeda H, Bharate GY, Daruwalla J. Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect. Eur J Pharm Biopharm 2009;71:409-19
   PubMed Web of Science ®Google Scholar
• Lorusso D, Di Stefano A, Scambia G, Pegylated liposomal doxorubicin-related palmar-plantar erythrodysesthesia (‘hand-foot’ syndrome). Ann Oncol 2007;18:1159-64
   PubMed Web of Science ®Google Scholar
• Gordon KB, Tajuddin A, VonRoenn J, Hand-foot syndrome associated with liposome-encapsulated doxorubicin therapy. Cancer 1995;75:2169-73
   PubMed Web of Science ®Google Scholar
• Negishi T, Koizumi F, Matsumura Y, NK105, a paclitaxel-incorporating micellar nanoparticle, is a more potent radiosensitising agent compared to free paclitaxel. Br J Cancer 2006;95:601-6
   PubMed Web of Science ®Google Scholar
• Hamaguchi T, Matsumura Y, Kakizoe T, NK105, a paclitaxel-incorporating micellar nanoparticle formulation, can extend in vivo antitumour activity and reduce the neurotoxicity of paclitaxel. Br J Cancer 2005;92:1240-6
   PubMed Web of Science ®Google Scholar
• Kim SC, Kim DW, Seo MH, In vivo evaluation of polymeric micellar paclitaxel formulation: toxicity and efficacy. J Control Release 2001;72:191-202
   PubMed Web of Science ®Google Scholar
• Nagano T, Yasunaga M, Matsumura Y, Antitumor activity of NK012 combined with cisplatin against small cell lung cancer and intestinal mucosal changes in tumor-bearing mouse after treatment. Clin Cancer Res 2009;15:4348-55
   PubMed Web of Science ®Google Scholar
• Kuroda J, Kuratsu J, Matsumura Y, Potent antitumor effect of SN-38-incorporating polymeric micelle, NK012, against malignant glioma. Int J Cancer 2009;124:2505-11
   PubMed Web of Science ®Google Scholar
• Nakajima TE, Yanagihara K, Matsumura Y, Antitumor effect of SN-38-releasing polymeric micelles, NK012, on spontaneous peritoneal metastases from orthotopic gastric cancer in mice compared with irinotecan. Cancer Res 2008;68:9318-22
   PubMed Web of Science ®Google Scholar
• Saito Y, Yasunaga M, Matsumura Y, Enhanced distribution of NK012, a polymeric micelle-encapsulated SN-38, and sustained release of SN-38 within tumors can beat a hypovascular tumor. Cancer Sci 2008;99:1258-64
   PubMed Web of Science ®Google Scholar
• Sumitomo M, Koizumi F, Matsumura Y, Novel SN-38-incorporated polymeric micelle, NK012, strongly suppresses renal cancer progression. Cancer Res 2008;68:1631-5
   PubMed Web of Science ®Google Scholar
• Nakajima TE, Yasunaga M, Matsumura Y, Synergistic antitumor activity of the novel SN-38-incorporating polymeric micelles, NK012, combined with 5-fluorouracil in a mouse model of colorectal cancer, as compared with that of irinotecan plus 5-fluorouracil. Int J Cancer 2008;122:2148-53
   PubMed Web of Science ®Google Scholar
• Koizumi F, Hamaguchi T, Matsumura Y, Novel SN-38-incorporating polymeric micelles, NK012, eradicate vascular endothelial growth factor-secreting bulky tumors. Cancer Res 2006;66:10048-56
   PubMed Web of Science ®Google Scholar
• Li Y, Kwon GS. Methotrexate ester of poly(ethylene oxide)-block-poly(2-hydroxyethyl-L-aspartamide). Part 1: effects of the level of methotrexate conjugation on the stabliity of micelles and on drug release. Pharm Res 2000;157:607-11
   Web of Science ®Google Scholar
• Bae Y, Fukushima S, Kataoka K. Design of environment-sensitive supramolecular assemblies for intracellular drug delivery: polymeric micelles that are responsive to intracellular pH change. Angew Chem Int Ed Engl 2003;42:4640-3
   PubMed Web of Science ®Google Scholar
• Bae Y, Fukushima S, Kataoka K. Preparation and biological characterization of polymeric micelle drug carriers with intracellular pH-triggered drug release property: tumor permeability, controlled subcellular drug distribution, and enhanced in vivo antitumor efficacy. Bioconjug Chem 2005;16:122-30
   PubMed Web of Science ®Google Scholar
• Bae Y, Nishiyama N, Kataoka K. In vivo antitumor activity of the folate-conjugated pH-sensitive polymeric micelle selectively releasing adriamycin in the intracellular acidic compartments. Bioconjug Chem 2007;18:1131-9
   PubMed Web of Science ®Google Scholar
• Lee ES, Gao Z, Bae YH. Recent progress in tumor pH targeting nanotechnology. J Control Release 2008;132:164-70
   PubMed Web of Science ®Google Scholar
• Na K, Sethuraman VT, Bae YH. Stimuli-sensitive polymeric micelles as anticancer drug carriers. Anticancer Agents Med Chem 2006;6:525-35
   PubMedGoogle Scholar
• Yokoyama M, Satoh A, Matsumura Y, Incorporation of water-insoluble anticancer drug into polymeric micelles and control of their particle size. J Control Release 1998;55:219-29
   PubMed Web of Science ®Google Scholar
• Matsumura Y, Yokoyama M, Kakizoe T. Reduction of the adverse effects of an antitumor agent, KRN 5500 by incorporation of the drug into polymeric micelles. Jpn J Cancer Res 1999;90:122-8
   PubMedGoogle Scholar
• Mizumura Y, Matsumura Y, Kakizoe T. Incorporation of the anticancer agent KRN 5500 into polymeric micelles diminishes the pulmonary toxicity. Jpn J Cancer Res 2002;93:1237-43
   PubMedGoogle Scholar
• Lavasanifar A, Samuel J, Kwon GS. Block copolymer micelles for the encapsulation and delivery of amphotericin B. Pharm Res 2002;19:418-22
   PubMed Web of Science ®Google Scholar
• Lavasanifar A, Samuel J, Kwon GS. Micelles self-assembled from poly(ethylene oxide)-block-poly(N-hexyl stearate L-aspartamide) by a solvent evaporation method; effect on the solubilization and hemolytic activity of amphotericin B. J Control Release 2001;77:155-60
   PubMed Web of Science ®Google Scholar
• Yokoyama M, Opanasopit P, Okano T. Polymer design and incorporation method for polymeric micelle carrier system containing water-insoluble anti-cancer agent camptothecin. J Drug Target 2004;12:373-84
   PubMed Web of Science ®Google Scholar
• Opanasopit P, Yokoyama M, Okano T. Block copolymer design for camptothecin incorporation into polymeric micelles for passive tumor targeting. Pharm Res 2004;21:2003-10
   Web of Science ®Google Scholar
• Yokoyama M, Kwon GS, Kataoka K. Preparation of micelle-forming polymer-drug conjugates. Bioconjugate Chem 1992;3:295-301
   PubMed Web of Science ®Google Scholar
• Hoes CJT, Potman W, Feijen J. Optimization of macromolecular prodrugs of the antitumor antibiotic adriamycin. J Control Release 1985;2:205-13
   Google Scholar
• Duncan R, Kopeckova-Rejmanova P, Kopecek J. Anticancer agents coupled to N-(2-hydroxypropyl)methacrylamide copolymers I. Evaluation of daunomycin and puromycin conjugates in vitro. Br J Cancer 1987;55:165-74
   PubMed Web of Science ®Google Scholar
• Endo N, Umemoto N, Hara T. A novel covalent modification of antibodies at their amino groups with retention of antigen-binding activity. J Immunol Methods 1987;104:253-8
   PubMed Web of Science ®Google Scholar
• Zunino F, Pratesi G, Micheloni A. Poly(carboxylic acid) polymers as carriers for anthracyclines. J Control Release 1989;10:65-73
   Web of Science ®Google Scholar
• Yamamoto T, Yokoyama M, Maitani Y, What are determining factors for stable drug incorporation into polymeric micelle carriers? Consideration on physical and chemical characters of the micelle inner core. J Control Release 2007;123:11-8
   PubMed Web of Science ®Google Scholar
• Kabanov AV, Batrakova EV, Alakhov VY. Pluronic block copolymers for overcoming drug resistance in cancer. Adv Drug Deliv Rev 2002;54:759-79
   PubMed Web of Science ®Google Scholar
• Kabanov AV, Batrakova EV, Alakhov VY. An essential relationship between ATP depletion and chemosensitizing activity of Pluronic block copolymers. J Control Release 2003;91:75-83
   PubMed Web of Science ®Google Scholar
• Sharma AK, Zhang L, Li S, Prevention of MDR development in leukemia cells by micelle-forming polymeric surfactant. J Control Release 2008;131:220-7
   PubMed Web of Science ®Google Scholar
• Yokoyama M, Inoue S, Sakurai Y, Preparation of adriamycin-conjugated poly(ethylene glycol)-poly(aspartic acid) block copolymer. A new type of polymeric anticancer agent. Makromolekulare Chem Rapid Commun 1987;8:431-5
   Google Scholar
• Yokoyama M, Miyauchi M, Inoue S, Characterization and anti-cancer activity of micelle-forming polymeric anti-cancer drug, adriamycin-conjugated poly(ethylene glycol)-poly(aspartic acid) block copolymer. Cancer Res 1990;50:1693-700
   PubMed Web of Science ®Google Scholar
• Yokoyama M, Okano T, Inoue S, Toxicity and antitumor activity against solid tumors of micelle-forming polymeric drug and its extremely long circulation in blood. Cancer Res 1991;51:3229-36
   PubMed Web of Science ®Google Scholar
• Kwon GS, Yokoyama M, Kataoka K, Enhanced tumor accumulation and prolonged circulation times of micelle-forming poly(ethylene oxide-aspartate) block copolymer-adriamycin conjugates. J Control Release 1994;29:17-23
   Web of Science ®Google Scholar
• Yokoyama M, Okano T, Fukushima S, Selective delivery of adriamycin to a solid tumor using a polymeric micelle carrier system. J Drug Targeting 1999;7:171-86
   PubMed Web of Science ®Google Scholar
• Yokoyama M, Okano T, Kataoka K, Improved synthesis of adriamycin-conjugated poly(ethylene oxide)-poly(aspartic acid) block copolymer and formation of unimodal micellar structure with controlled amount of physically entrapped adriamycin. J Control Release 1994;32:269-77
   Web of Science ®Google Scholar
• Yokoyama M, Fukushima S, Okano T, Characterization of physical entrapment and chemical conjugation of adriamycin in polymeric micelles and their design for in vivo delivery to a solid tumor. J Control Release 1998;50:79-92
   PubMed Web of Science ®Google Scholar
• Nakanishi T, Matsumura Y, Yokoyama M, Development of the polymer micelle carrier system for doxorubicin. J Control Release 2001;74:295-302
   PubMed Web of Science ®Google Scholar
• Tsukioka Y, Matsumura Y, Kakizoe T, Pharmaceutical and biomedical differences between micellar doxorubicin (NK911) and liposomal doxorubicin (Doxil). Jpn J Cancer Res 2002;93:1145-53
   PubMedGoogle Scholar
• Kawaguchi T, Yamamoto T, Yokoyama M, Histological study on side effects and tumor targeting of a block copolymer micelle on rats. J Control Release 2009;136:240-6
   PubMed Web of Science ®Google Scholar
• Opanasopit P, Y Maitani, T Okano, Influence of serum and albumins from different species on stability of camptothecin-loaded micelles. J Control Release 2005;104:313-21
   PubMed Web of Science ®Google Scholar
• Watanabe M, Yokoyama M, Maitani Y, Preparation of camptothecin-loaded polymeric micelles and evaluation of their incorporation and circulation stability. Int J Pharm 2006;308:183-9
   PubMed Web of Science ®Google Scholar
• Kawano K, Yokoyama M, Maitani Y, Enhanced antitumor effect of camptothecin loaded in long-circulating polymeric micelles. J Control Release 2006;112:329-32
   PubMed Web of Science ®Google Scholar
• Hayama A, Kawano K, Maitani Y, Polymeric micelles modified by folate-PEG-lipid for targeted drug delivery to cancer cells in vitro. J Nanosci Nanotechnol 2008;8:3085-90
   PubMed Web of Science ®Google Scholar
• Kawakami S, Opanasopit P, Hashida M, Biodistribution characteristics of all-trans retinoic acid incorporated in liposomes and polymeric micelles following intravenous administration. J Pharm Sci 2005;94:2606-15
   PubMed Web of Science ®Google Scholar
• Chansri N, Kawakami S, Hashida M, Anti-tumor effect of all-trans retinoic acid loaded polymeric micelles in solid tumor bearing mice. Pharm Res 2008;25:428-34
   PubMed Web of Science ®Google Scholar
• Okuda T, Kawakami S, Hashida M, Block copolymer design for stable encapsulation of N-(4-hydroxyphenyl)retinamide into polymeric micelles in mice. Int J Pharm 2008;357:318-22
   PubMed Web of Science ®Google Scholar
• Okuda T, Kawakami S, Hashida M, Enhanced in vivo antitumor efficacy of fenretinide encapsulated in polymeric micelles. Int J Pharm 2006;373:100-6
   Web of Science ®Google Scholar
• Satoh T, Kagechika H, Yokoyama M, Encapsulation of the synthetic retinoids Am80 and LE540 into polymeric micelles and the retinoids' release control. J Control Release 2009;136:187-95
   PubMed Web of Science ®Google Scholar
• Koide H, Yokoyama M, Oku N, Particle size-dependent triggering of accelerated blood clearance phenomenon. Int J Pharm 2008;362:197-200
   PubMed Web of Science ®Google Scholar
• Dams ET, Storm G, Boerman OC, Accelerated blood clearance and altered biodistribution of repeated injections of sterically stabilized liposomes. J Pharmacol Exp Ther 2000;292:1071-9
   PubMed Web of Science ®Google Scholar
• Laverman P, Carstens MG, Storm G, Factors affecting the accelerated blood clearance of polyethylene glycol-liposomes upon repeated injection. J Pharmacol Exp Ther 2001;298:607-12
   PubMed Web of Science ®Google Scholar
• Ishida T, Ichihara M, Kiwada H, Spleen plays an important role in the induction of accelerated blood clearance of PEGylated liposomes. J Control Release 2006;115:243-50
   PubMed Web of Science ®Google Scholar
• Ishida T, Kiwada H. Accelerated blood clearance (ABC) phenomenon upon repeated injection of PEGylated liposomes. Int J Pharm 2008;354:56-62
   PubMed Web of Science ®Google Scholar
• Nishiyama N, Matsumura Y, Kataoka K, Novel cisplatin-incorporated polymeric micelles can eradicate solid tumors in mice. Cancer Res 2003;63:8977-83
   PubMed Web of Science ®Google Scholar
• Uchino H, Matsumura Y, Kakizoe T, Cisplatin-incorporating polymeric micelles (NC-6004) can reduce nephrotoxicity and neurotoxicity of cisplatin in rats. Br J Cancer 2005;93:678-87
   PubMed Web of Science ®Google Scholar